|
市場調査レポート
世界の製薬およびバイオテクノロジー市場におけるサイエンティフィックビジネスインテリジェンス(Sci-BI)
Strategic Analysis of Global Scientific Business Intelligence (Sci-BI) in Pharmaceutical and Biotechnology Markets
|
Abstract
This strategic analysis identifies the current trends in scientific business
intelligence (Sci-BI) in pharmaceutical and biotechnology markets. Major
global healthcare trends are analyzed and the impacts on Sci-BI are
delineated. A close look at drivers and restraints in the Sci-BI space
revealed interesting growth stimulators while also identifying critical road
blocks in the growth of the Sci-BI market. A step by step analysis of the R&D
cost distribution in pharma/biotech was carried out together with a
competitive landscape analysis of the different players in this niche market
segment.
Table of Contents
1. INTRODUCTION
Title Page
Disclaimer
Certification
Table of Contents
Notes on Methodology
2. MARKET INTRODUCTION AND SEGMENTATION
Introduction
Segmentation
3. MAJOR GLOBAL TRENDS IN HEALTHCARE
Major Global Healthcare Trends
- Major Global Healthcare Trends
4. CURRENT INDUSTRY TRENDS IN SCI-BI
Current Industry Trends in Sci-BI
- Current Industry Trends in Sci-BI
5. SCI-BI DRIVERS AND RESTRAINTS
Overall Market Drivers and Restraints
- Overall Market Drivers and Restraints
Sci-BI Drivers
- Drivers for Sci-BI in Pharma/Biotech Ranked in Order of Impact 2008-2015
Sci-BI Restraints
- Restraints for Sci-BI in Pharma/Biotech Ranked in Order of Impact 2008-2015
6. SCI-BI OPPORTUNITY ANALYSIS
Opportunity Analysis - Major Areas of Convergence
- Opportunity Analysis - Major Areas of Convergence
Opportunity Analysis: Growth Drivers for Sci-BI & Workflow Management
- Opportunity Analysis: Growth Drivers for Sci-BI & Workflow Management
7. PHARMA/BIOTECH R&D & SCI-BI
The ROI Challenge for Pharma
- The ROI Challenge for Pharma
Pharmaceutical R&D Expenditure
- Pharmaceutical R&D Expenditure
End to End Sci-BI Services
- End to End Sci-BI Services
8. SCI-BI MARKETS COMPETITIVE LANDSCAPE
Sci-BI Markets: Competitive Landscape
- Competitive Analysis by Company
9. CHALLENGES AND CONCLUSIONS
Challenges & Conclusions
10. ABOUT FROST & SULLIVAN
About Frost & Sullivan
|
